Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $79000.0.

  • Healthequity's Change in Receivables rose 10453.5% to $79000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $4.5 million, marking a year-over-year decrease of 5697.46%. This contributed to the annual value of $13.1 million for FY2025, which is 6273.27% up from last year.
  • Latest data reveals that Healthequity reported Change in Receivables of $79000.0 as of Q4 2025, which was up 10453.5% from -$5.1 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Change in Receivables ranged from a high of $11.3 million in Q1 2025 and a low of -$5.8 million during Q3 2023
  • Moreover, its 5-year median value for Change in Receivables was $1.2 million (2022), whereas its average is $2.2 million.
  • The largest annual percentage gain for Healthequity's Change in Receivables in the last 5 years was 197183.67% (2022), contrasted with its biggest fall of 40000.0% (2022).
  • Over the past 5 years, Healthequity's Change in Receivables (Quarter) stood at $9.9 million in 2021, then tumbled by 127.48% to -$2.7 million in 2022, then soared by 232.84% to $3.6 million in 2023, then crashed by 148.39% to -$1.7 million in 2024, then surged by 104.54% to $79000.0 in 2025.
  • Its Change in Receivables stands at $79000.0 for Q4 2025, versus -$5.1 million for Q3 2025 and -$1.8 million for Q2 2025.